Design and synthesis of new anticancer glycyrrhetinic acids and oleanolic acids

Rui Wang, Qing-Xuan Zheng, Wei Wang, Ling Feng, Hui-Jing Li*, Qi-Yong Huai*

*Corresponding author for this work

    Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

    10 Citations (Scopus)

    Abstract

    A series of new glycyrrhetinic acids and oleanolic acids has been designed and synthesized based on the principles of combinatorial chemical synthesis. Their anticancer activities were further studied by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method with hepatocellular carcinoma (Hep-G2), breast cancer (MCF-7) cell lines and a normal hepatic cell (LO2). Cytotoxicity tests (in vitro) indicated that compound 6a showed the highest cytotoxicity with the lowest IC50 values of 23.34 μM on Hep-G2 cells, 12.23 μM on MCF-7 cells, and 44.47 μM on LO2, which would widen the structural diversity of these anticancer targets and confirm the perspectives of further investigations.
    Original languageEnglish
    Pages (from-to)703-710
    JournalBiological and Pharmaceutical Bulletin
    Volume40
    Issue number5
    DOIs
    Publication statusPublished - Feb 2017

    Research Keywords

    • Anticancer
    • Glycyrrhetinic acid
    • Oleanolic acid
    • Synthesis

    Fingerprint

    Dive into the research topics of 'Design and synthesis of new anticancer glycyrrhetinic acids and oleanolic acids'. Together they form a unique fingerprint.

    Cite this